In the future, studies investigating the molecular network of LARS and DKK4 in human CRC cell lines are needed to clarify the molecular mechanism by which DKK4 low expression in the presence of LARS high expression acts as an independent poor prognostic factor in CRC patients. The gene discussed is LARS1; the disease is colorectal carcinoma.